DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹8.00 Cr | ₹257 Cr | ₹89 Cr | ₹89 Cr | ₹7.06 Cr |
What is the latest Contingent Liabilities ratio of DIVIS LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹8.00 Cr |
Mar2024 | ₹257 Cr |
Mar2023 | ₹89 Cr |
Mar2022 | ₹89 Cr |
Mar2021 | ₹7.06 Cr |
How is Contingent Liabilities of DIVIS LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹8.00 Cr | -96.89 | |
Mar2024 | ₹257 Cr | 188.76 | |
Mar2023 | ₹89 Cr | -0.03 | |
Mar2022 | ₹89 Cr | 1,161.05 | |
Mar2021 | ₹7.06 Cr | - |
Compare Contingent Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹160,650.1 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,368.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,641.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
CIPLA | ₹123,419.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,176.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics | |
MANKIND PHARMA | ₹105,776.0 Cr | 1.1% | -0.2% | 11% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0% |
1.1% |
13.4% |
SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses